New Alzheimer's pill tested in search for better treatment
Disease control
Completed
This study tested an experimental drug called 50561 to see if it could help people with mild to moderate Alzheimer's disease. 68 participants were randomly assigned to receive either the drug or a placebo (a dummy pill) for 24 weeks. Researchers measured changes in memory, thinki…
Phase: PHASE2 • Sponsor: Beijing Joekai Biotechnology LLC • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC